May 19, 2026

What Really Helps People Quit Smoking

What Really Helps People Quit Smoking

Whether people try to quit smoking depends heavily on public health policies in their respective countries – whether they are successful, however, depends primarily on their personal environment and behavior. This was the finding of researchers from the German Cancer Research Center (DKFZ) in an international study.

The researchers analyzed data from over 50,000 smokers from 29 countries across 5 continents and combined this with information on national tobacco control measures from the World Health Organization (WHO). Using machine learning, they were able to identify key factors influencing attempts to quit smoking and their success.

Policy provides the impetus…

The results clearly show that strict tobacco prevention laws—such as smoking bans, warning labels, or higher tobacco taxes—increase the likelihood that people will even attempt to quit smoking. “Policy measures provide the decisive impetus,” says study lead Titus Brinker. “Countries with comprehensive tobacco control measures record more attempts to quit smoking than countries that have implemented fewer tobacco control measures.”

…but success depends on individual factors

Whether a person succeeds in quitting smoking, however, is usually determined by their personal environment. It is particularly important whether other people in their household smoke. Those surrounded by smokers have significantly lower chances of quitting permanently. In addition, individual factors such as the severity of nicotine dependence play a major role: Those who reach for a cigarette early after waking up, or who smoke heavily, have a harder time quitting successfully.

The study makes it clear that successful tobacco prevention requires a two-pronged approach:

  • consistent tobacco control measures that motivate people to quit
  • targeted support for individual smokers, particularly consideration from other smokers in their social environment

Tobacco use causes more than seven million deaths worldwide each year and is one of the greatest preventable health risks. “But successfully quitting smoking is not just a matter of willpower. It is strongly influenced by one’s social environment, living conditions, and the political framework of one’s home country, says Christoph Wies, the study’s first author. Titus Brinker adds: “Our findings are intended to help make future measures more effective and thus enable more people to quit smoking permanently.”


Wies C, Al Ssabbagh M, Elango V, Schiavone S, Anderson CL, Theilmann M, Geldsetzer P, Hoe C, Winkler V, Brinker TJ. Tobacco control policies predict quit attempts, but household smoking predicts cessation success across 29 countries. Tobacco Control. 2026, DOI: 10.1136/tc-2025-059403
https://tobaccocontrol.bmj.com/content/early/2026/05/07/tc-2025-059403

Our latest News

discover more
Vaccine Against Brain Tumors Shows Promising Long-Term Results

Vaccine Against Brain Tumors Shows Promising Long-Term Results

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital, and numerous partner institutions* have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic […]

VectorBuilder Partners with MaxCyte® to Advance Clinical-Grade Cell Engineering

VectorBuilder Partners with MaxCyte® to Advance Clinical-Grade Cell Engineering

The next-generation platform integrates VectorBuilder’s regulatory-compliant gene delivery technology with MaxCyte’s clinically validated electroporation platform to enable robust, scalable, and reliable clinical-grade cell engineering. Chicago, IL & Rockville, MD – June 23, 2026 – VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering company providing enabling platform technologies to […]

LEEI-Platform eFIT is Available to Industry and Research

LEEI-Platform eFIT is Available to Industry and Research

KyooBe Tech is making its innovative vaccine development platform available to industry and research partners:Enabling faster and scalable vaccine production using Low-Energy Electron Irradiation (LEEI). Flexible Vaccine Manufacturing for Emerging Infectious Diseases Recent infectious disease events—from hantavirus outbreaks and meningitis cases to recurring disease outbreaks in livestock farming—highlight the need for flexibly scalable vaccine manufacturing […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp